Jason Drew Smith, General Counsel at UroGen Pharma Ltd. (URGN), sold 3,800 shares at $18.01 ($68K) on 2023-08-31, disclosed to the SEC on 2023-09-05.
Open-market sale of $68k URGN by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| URGN | SELL | 2025-09-09 | $29K | — | Filing → |
| URGN | SELL | 2025-07-30 | $288K | — | Filing → |
| URGN | SELL | 2025-02-04 | $82K | — | Filing → |